Status:
COMPLETED
Assessment of the Efficacy of Stromal Vascular Fraction Treatment for Knee Osteoarthritis
Lead Sponsor:
University of Andorra
Conditions:
Knee Osteoarthritis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
One-year follow-up prospective observational study involving male and female patients (over 18-years-old) with unilateral or bilateral knee osteoarthritis treated with intraarticular injection of stro...
Detailed Description
The research consists on one-year follow-up prospective observational study. It involves male and female patients (over 18-years-old) with unilateral or bilateral knee osteoarthritis treated with intr...
Eligibility Criteria
Inclusion
- Male and female over 18 years of age patients affected from unilateral or bilateral symptomatic knee osteoarthritis (KOA), determined by the diagnostic criteria of the American College of Rheumatology. Any degree of the Kellgren and Lawrence classification for KOA is included. Patients included must have KOA symptoms more than 6 months. Symptomatology must remain despite having done conventional treatment for KOA.
Exclusion
- Suspicion, diagnosis or history of active or recent joint infection (less than 6 months)
- Neurological deficit in the affected limb
- Pregnant or breastfeeding women
- Positive serology for hepatitis B, hepatitis C and / or HIV
- Magnetic resonance imaging without pathological alterations
- Knee infiltration with glucocorticoids, hyaluronic acid, platelet - rich plasma and / or other regenerative medicine therapies in the last 3 months.
- Medical conditions, including the diagnosis of oncological pathology or infectious and severe heart, kidney or liver disease, which contraindicate sedation or liposuction procedure.
- History or diagnosis of dementia or higher functions unpreserved, which interfere communication.
- Not having the necessary skills and / or electronic devices necessary (even their relatives or acquaintances, or they can not help them) to complete the online questionnaires.
Key Trial Info
Start Date :
September 20 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 7 2022
Estimated Enrollment :
66 Patients enrolled
Trial Details
Trial ID
NCT04749758
Start Date
September 20 2018
End Date
December 7 2022
Last Update
December 9 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CelularClinic
Les Escaldes, Andorra, AD700